HE4 as a Biomarker for Endometrial Cancer

SIMPLE SUMMARY: There are currently no blood biomarkers approved for routine clinical use in endometrial cancer. Serum human epididymis protein 4 (HE4) is significantly higher in patients with endometrial cancer compared to patients without endometrial cancer and is associated with a poorer prognosi...

Descripció completa

Dades bibliogràfiques
Autors principals: Behrouzi, Roya, Barr, Chloe E., Crosbie, Emma J.
Format: Online Article Text
Idioma:English
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507549/
https://www.ncbi.nlm.nih.gov/pubmed/34638250
http://dx.doi.org/10.3390/cancers13194764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507549/
https://www.ncbi.nlm.nih.gov/pubmed/34638250
http://dx.doi.org/10.3390/cancers13194764

Ítems similars